Literature DB >> 8144980

Characterization of cat dander-specific T lymphocytes from atopic patients.

R J van Neerven1, M M van de Pol, F J van Milligen, H M Jansen, R C Aalberse, M L Kapsenberg.   

Abstract

Fel d I, the major cat dander allergen, is recognized by serum IgE of more than 80% of all cat-allergic patients. Because IgE synthesis by B lymphocytes is under the control of T lymphocytes, we studied the specificity and lymphokine production profiles of cat dander-specific T lymphocytes. Polyclonal cat dander-specific T cell lines were found to react with purified Fel d I, but not with cat albumin, the only other characterized cat allergen. Similarly, within a panel of CD4+ T lymphocyte clones (TLC) that was generated from these cat dander-specific T cell lines, 5 of 16 TLC were found to react with Fel d I, and 0 of 16 with cat albumin. The remaining 11 TLC were shown to recognize at least two different proteins. In general, the TLC had a high IL-4/IFN-gamma production ratio, and could recognize the cat dander extract in an HLA-DR, HLA-DQ, or HLA-DP restricted manner. In addition, five distinct T cell epitopes of Fel d I were identified by using a panel of overlapping synthetic peptides of both chains of Fel d I. The data presented here indicate that, even though multiple proteins in cat dander extract are recognized by T lymphocytes of allergic patients, Fel d I, the major IgE binding allergen, is also important in T cell activation. The fact that the cat-specific TLC are Th2-like indicates that these cells may play an important role in the pathophysiology of allergic responses to cat allergens. However, the diversity of HLA-class II restriction of cat dander- and Fel d I-specific TLC and the presence of multiple T cell epitopes in the allergen may complicate future immunotherapies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8144980

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

Review 1.  Molecular characterization of allergens.

Authors:  S S Mohapatra; R F Lockey
Journal:  Clin Rev Allergy Immunol       Date:  2001-10       Impact factor: 8.667

Review 2.  Allergen-Specific CD4(+) T Cells in Human Asthma.

Authors:  Morris F Ling; Andrew D Luster
Journal:  Ann Am Thorac Soc       Date:  2016-03

3.  Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy.

Authors:  F Ferreira; K Hirtenlehner; A Jilek; J Godnik-Cvar; H Breiteneder; R Grimm; K Hoffmann-Sommergruber; O Scheiner; D Kraft; M Breitenbach; H J Rheinberger; C Ebner
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

Review 4.  Immunoregulatory T cell epitope peptides: the new frontier in allergy therapy.

Authors:  S R Prickett; J M Rolland; R E O'Hehir
Journal:  Clin Exp Allergy       Date:  2015-06       Impact factor: 5.018

5.  Ara h 1 CD4+ T cell epitope-based peptides: candidates for a peanut allergy therapeutic.

Authors:  S R Prickett; A L Voskamp; T Phan; A Dacumos-Hill; S I Mannering; J M Rolland; R E O'Hehir
Journal:  Clin Exp Allergy       Date:  2013-06       Impact factor: 5.018

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.